Moderna, Pfizer say updated Covid vaccines were effective against highly mutated BA.2.86 variant in trials
Publishing timestamp: 2023-09-07 09:37:15
Summary
The article discusses how new Covid vaccines from Moderna and Pfizer have generated a strong immune response against the highly mutated omicron variant BA.2.86. The vaccines are also expected to be effective against other newer variants of the virus. The companies are awaiting potential approvals from the FDA to roll out new vaccines targeting another omicron strain called XBB.1.5. The article also mentions the rise in Covid cases and hospitalizations due to variants such as Eris and FL.1.5.1.
Sentiment: NEUTRAL
Keywords: moderna inc, vaccinations, novavax inc, business news, pharmaceuticals, immunizations, business, breaking news, pfizer inc, biotech and pharmaceuticals, biotechnology, covid-19 vaccine rollout, coronavirus, health care industry, covid-19,